Parallel imports - an overview for pharma - Feature | PharmiWeb.com - 1 views
-
The craving for cheap drugs has never been greater. For those patients and policymakers in developing countries, the existence of parallel imports is less a concern than a blessing. Yet for pharmaceutical companies themselves, there is the concern that an increasing trade in parallel imports would severely damage research-intensive activities and ultimately slow down the development of the very same drugs that are being traded in ‘grey’ markets today.
-
Mentioned in the Something Borrowed article, the United States is trying to swing that parallel imports for pharmaceuticals violates the intellectual property of the western drug producers. -
interesting connection there!
